These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 29742944)

  • 1. Subcentimetric Incidental Intrahepatic Cholangiocarcinoma in an Explant Liver: Diagnostic Difficulty of a Rare Entity.
    Mitra S; Geethanjali G; Rathi S; Behera A; Das A
    Int J Surg Pathol; 2018 Dec; 26(8):739-744. PubMed ID: 29742944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic Cholangiocarcinoma in the Liver Explant After Liver Transplantation: Histological Differentiation and Prognosis.
    Takahashi K; Obeid J; Burmeister CS; Bruno DA; Kazimi MM; Yoshida A; Abouljoud MS; Schnickel GT
    Ann Transplant; 2016 Apr; 21():208-15. PubMed ID: 27068242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma.
    Sasaki M; Sato Y; Nakanuma Y
    Histopathology; 2021 Jan; 78(2):310-320. PubMed ID: 33405289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Clinical Features and Outcomes Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in the United States.
    Lee YT; Wang JJ; Luu M; Noureddin M; Nissen NN; Patel TC; Roberts LR; Singal AG; Gores GJ; Yang JD
    Hepatology; 2021 Nov; 74(5):2622-2632. PubMed ID: 34114675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined hepatocellular-cholangiocarcinoma].
    Jeen YM; Jin SY
    Korean J Hepatol; 2007 Dec; 13(4):571-5. PubMed ID: 18159156
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytologic features of fibrolamellar carcinoma with mucin production: a rare variant of combined hepatocellular-cholangiocarcinoma.
    Rosa M; Mohammadi A
    Diagn Cytopathol; 2014 May; 42(5):431-5. PubMed ID: 23008149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in Diagnosing and Reporting Cholangiocarcinoma.
    El Jabbour T; Molnar A; Lagana SM
    Surg Pathol Clin; 2023 Sep; 16(3):599-608. PubMed ID: 37536891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined hepatocellular carcinoma and cholangiocellular carcinoma].
    Maeda Y; Nishida M; Mori N; Tamesa T; Okada T; Tangoku A; Oka M
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():401-5. PubMed ID: 11761981
    [No Abstract]   [Full Text] [Related]  

  • 10. Defining the biology of intrahepatic cholangiocarcinoma: molecular pathways and early detection of precursor lesions.
    Gibiino G; Fabbri C; Fagiuoli S; Ianiro G; Fornelli A; Cennamo V
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):730-741. PubMed ID: 28272710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological aspects of mucinous cholangiocarcinoma: A single-center experience and systematic review.
    Laohawetwanit T; Klaikaew N
    Pathol Int; 2020 Sep; 70(9):661-670. PubMed ID: 32638458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is nestin a diagnostic marker for combined hepatocellular-cholangiocarcinoma?
    Sasaki M; Sato Y; Nakanuma Y
    Histopathology; 2022 Apr; 80(5):859-868. PubMed ID: 35076959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Indications for liver biopsy in liver tumors].
    Stölzel U; Tannapfel A; Wittekind C; Hamm B; Schuppan D
    Dtsch Med Wochenschr; 2000 Sep; 125(36):1041-4. PubMed ID: 11022600
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidental Intra-Hepatic Cholangiocarcinoma and Hepatocholangiocarcinoma in Liver Transplantation: A Single-Center Experience.
    Serra V; Tarantino G; Guidetti C; Aldrovandi S; Cuoghi M; Olivieri T; Assirati G; De Ruvo N; Magistri P; Ballarin R; Di Benedetto F
    Transplant Proc; 2016 Mar; 48(2):366-9. PubMed ID: 27109957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary intrahepatic small-cell carcinoma arising from combined hepatocellular and cholangiocarcinomas.
    Khaw YL; Nolan N; Heaslip I; McCormick PA; Sheahan K
    J Clin Oncol; 2011 Jul; 29(21):e630-3. PubMed ID: 21606429
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined hepatocellular-cholangiocarcinoma. Cytologic findings in four cases.
    Dusenbery D
    Acta Cytol; 1997; 41(3):903-9. PubMed ID: 9167724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synchronous double primary hepatic cancer: hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
    Kim JO; Jun DW; Jang K
    Korean J Gastroenterol; 2013 Aug; 62(2):135-9. PubMed ID: 24133714
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative analysis of immunohistochemical markers for differential diagnosis of hepatocelluar carcinoma and cholangiocarcinoma.
    Ryu HS; Lee K; Shin E; Kim SH; Jing J; Jung HY; Lee H; Jang JJ
    Tumori; 2012; 98(4):478-84. PubMed ID: 23052165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Long-term follow-up of liver transplantation in incidental intrahepatic cholangiocarcinoma and mixed hepatocellular-cholangiocarcinoma".
    Garcia-Moreno V; Justo-Alonso I; Fernandez-Fernandez C; Rivas-Duarte C; Aranda-Romero B; Loinaz-Segurola C; Jimenez-Romero C; Caso-Maestro Ó
    Cir Esp (Engl Ed); 2023 Sep; 101(9):624-631. PubMed ID: 37119950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating Hepatobiliary Cancers: The Oncology Way.
    Galle PR
    Dig Dis; 2017; 35(4):384-386. PubMed ID: 28468016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.